Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) ROCE % : 19.13% (As of Mar. 2017)

View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aoxing Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2017 was 19.13%.

Aoxing Pharmaceutical Co ROCE % Historical Data

The historical data trend for Aoxing Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co ROCE % Chart

Aoxing Pharmaceutical Co Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

ROCE %

Get a 7-Day Free Trial

-3.40

-29.44

-30.47

111.05

41.22

Aoxing Pharmaceutical Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
ROCE %	Get a 7-Day Free Trial															31.35	-37.60	36.50	5.41	19.13

Aoxing Pharmaceutical Co ROCE % Calculation

Aoxing Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Jun. 2016 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2016 )		(A: Jun. 2015 )		(A: Jun. 2016 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2016 )		(A: Jun. 2015 )		(A: Jun. 2016 )
	=	6.228	/	( ( (53.041 - 41.24)	+	(56.232 - 37.816) )	/ 2 )
	=	6.228	/	( (11.801	+	18.416)	/ 2 )
	=	6.228	/	15.1085
	=	41.22 %

Aoxing Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2017 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2017 )		(Q: Dec. 2016 )		(Q: Mar. 2017 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2017 )		(Q: Dec. 2016 )		(Q: Mar. 2017 )
	=	3.512	/	( ( (58.724 - 40.511)	+	(62.466 - 43.971) )	/ 2 )
	=	3.512	/	( ( 18.213	+	18.495 )	/ 2 )
	=	3.512	/	18.354
	=	19.13 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2017) EBIT data.

Aoxing Pharmaceutical Co (OTCPK:AOXG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aoxing Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217

Website

http://www.aoxingpharma.com

Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.

Executives

Wilfred Chow	officer: Chief Financial Officer	30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea	director	C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo	director, officer: Secretary	80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines